Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease.

"Conflict of interest statement This paper is based on proceedings of a European panel of experts in haematology which convened in Paris, France on 18 October 2006. The experts were invited to join the panel by Genzyme Corporation, Cambridge MA. Genzyme Corporation also provided an unrestricted educational grant to support the meeting and this publication. While Genzyme encourages discussion on the treatment and management of Gaucher disease, the opinions and recommendations expressed in this paper were made and agreed by the panel members alone and do not necessarily reflect the opinions or recommendations of Genzyme Corporation. Editorial support was provided by Conscience Creative LLP, Leatherhead, UK."

"Conflict of interest statement: This paper is based on proceedings of a European panel of experts in haematology which convened in Paris, France on 18 October 2006. The experts were invited to join the panel by Genzyme Corporation, Cambridge MA. Genzyme Corporation also provided an unrestricted educational grant to support the meeting and this publication. While Genzyme encourages discussion on the treatment and management of Gaucher disease, the opinions and recommendations expressed in this paper were made and agreed by the panel members alone and do not necessarily reflect the opinions or recommendations of Genzyme Corporation. Editorial support was provided by Conscience Creative LLP, Leatherhead, UK."